[go: up one dir, main page]

AU2017902307A0 - Treatment of alzheimer's disease - Google Patents

Treatment of alzheimer's disease

Info

Publication number
AU2017902307A0
AU2017902307A0 AU2017902307A AU2017902307A AU2017902307A0 AU 2017902307 A0 AU2017902307 A0 AU 2017902307A0 AU 2017902307 A AU2017902307 A AU 2017902307A AU 2017902307 A AU2017902307 A AU 2017902307A AU 2017902307 A0 AU2017902307 A0 AU 2017902307A0
Authority
AU
Australia
Prior art keywords
alzheimer
disease
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2017902307A
Inventor
Michael Lionel Selley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xenexus Pharmaceuticals Pty Ltd
Original Assignee
Xenexus Pharmaceuticals Pty Ltd
Filing date
Publication date
Application filed by Xenexus Pharmaceuticals Pty Ltd filed Critical Xenexus Pharmaceuticals Pty Ltd
Publication of AU2017902307A0 publication Critical patent/AU2017902307A0/en
Abandoned legal-status Critical Current

Links

AU2017902307A 2017-06-16 Treatment of alzheimer's disease Abandoned AU2017902307A0 (en)

Publications (1)

Publication Number Publication Date
AU2017902307A0 true AU2017902307A0 (en) 2017-06-29

Family

ID=

Similar Documents

Publication Publication Date Title
EP3268086A4 (en) Lsd for the treatment of alzheimer's disease
EP3261721A4 (en) Use of pridopidine to improve cognitive function and for treating alzheimer's disease
IL263188B (en) Treatment for parkinson's disease
HUE071155T2 (en) Biscoline tetrathiomolybdate for the treatment of Wilson's disease
PT3458045T (en) Treatment of meniere's disease
LT3413870T (en) IGMESIN FOR THE TREATMENT OF ALZHEIMER'S DISEASE
PL3137097T3 (en) Treatment and prevention of alzheimer's disease (ad)
IL254252A0 (en) Tetrahydrofurane-fused aminohydrothiazine derivatives which are useful in the treatment of alzheimer's disease
PL3352742T3 (en) Compositions comprising triterpenoids for the treatment of alzheimer's disease and parkinson's disease
PT3137094T (en) Treatment and prevention of alzheimer's disease (ad)
EP3634979A4 (en) Compositions and methods for treating alzheimer's disease
EP3601570A4 (en) Methods of treating alzheimer's disease
ZA202001588B (en) Method of treating alzheimer's disease
HUE037501T2 (en) Treatment and prevention of alzheimer's disease (ad)
AU2017902307A0 (en) Treatment of alzheimer's disease
AU2017902309A0 (en) Treatment of alzheimer's disease
HK40103246A (en) Aav treatment of huntington's disease
AU2018903530A0 (en) Treatment for Alzheimer's Disease
AU2015904411A0 (en) Compositions and methods for the treatment of Alzheimer's disease
HK40052061A (en) Methods of treatment and prevention of alzheimer's disease
GB201819758D0 (en) Medicine for the treatment of Alzheimer's disease
HK40022834B (en) Compositions and methods for treating alzheimer's disease
HK40024508A (en) Compositions and methods for treating alzheimer's disease
GB201511453D0 (en) Treatment of alzheimer's disease
ZA201807944B (en) Treatment for parkinson's disease